![Electrochemical Synthesis of Core–Shell Catalysts for Electrocatalytic Applications - Kulp - 2010 - ChemPhysChem - Wiley Online Library Electrochemical Synthesis of Core–Shell Catalysts for Electrocatalytic Applications - Kulp - 2010 - ChemPhysChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/e42fad2d-eb97-4561-80c4-484847cbcfef/mcontent.gif)
Electrochemical Synthesis of Core–Shell Catalysts for Electrocatalytic Applications - Kulp - 2010 - ChemPhysChem - Wiley Online Library
![Antimicrobial effect and biocompatibility of novel metallic nanocrystalline implant coatings - Gosau - 2016 - Journal of Biomedical Materials Research Part B: Applied Biomaterials - Wiley Online Library Antimicrobial effect and biocompatibility of novel metallic nanocrystalline implant coatings - Gosau - 2016 - Journal of Biomedical Materials Research Part B: Applied Biomaterials - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/94bcc8cd-71fe-4a8a-9293-6af5738051cd/jbmb33376-fig-0001-m.jpg)
Antimicrobial effect and biocompatibility of novel metallic nanocrystalline implant coatings - Gosau - 2016 - Journal of Biomedical Materials Research Part B: Applied Biomaterials - Wiley Online Library
![PDF) Guideline “Implantable hearing aids”—short version: German S2k guideline of the Working Group of German-Speaking Audiologists, Neurootologists and Otologists (ADANO), of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO) in PDF) Guideline “Implantable hearing aids”—short version: German S2k guideline of the Working Group of German-Speaking Audiologists, Neurootologists and Otologists (ADANO), of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO) in](https://i1.rgstatic.net/publication/327893052_Guideline_Implantable_hearing_aids-short_version_German_S2k_guideline_of_the_Working_Group_of_German-Speaking_Audiologists_Neurootologists_and_Otologists_ADANO_of_the_German_Society_of_Oto-Rhino-Laryn/links/5bc0cb2d92851c88fd65c322/largepreview.png)
PDF) Guideline “Implantable hearing aids”—short version: German S2k guideline of the Working Group of German-Speaking Audiologists, Neurootologists and Otologists (ADANO), of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery (DGHNO) in
![Plexin-B1 and semaphorin 4D cooperate to promote perineural invasion in a RhoA/ROK-dependent manner. - Abstract - Europe PMC Plexin-B1 and semaphorin 4D cooperate to promote perineural invasion in a RhoA/ROK-dependent manner. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3349891/bin/gr7.jpg)
Plexin-B1 and semaphorin 4D cooperate to promote perineural invasion in a RhoA/ROK-dependent manner. - Abstract - Europe PMC
Individuelle Implantologie, Dr. Merk und Partner, Bad Nauheim | Dr. Martin Merk, Master of Science der Implantologie, führt in seiner Praxis in Bad Nauheim täglich Implantationen durch. Dr. Martin Merk arbeitet mit...
![Frauenarzt Bad Nauheim Jürgen Brand, Dr. med. Kerstin Stoy, Robert Mikolas, Bettina Bößenecker Frauenärztin / Startseite Frauenarzt Bad Nauheim Jürgen Brand, Dr. med. Kerstin Stoy, Robert Mikolas, Bettina Bößenecker Frauenärztin / Startseite](https://map01.monks.de/osm/15/17180/11060.png)
Frauenarzt Bad Nauheim Jürgen Brand, Dr. med. Kerstin Stoy, Robert Mikolas, Bettina Bößenecker Frauenärztin / Startseite
![PDF) A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction: A Phase 2a study of BMS-986231 PDF) A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction: A Phase 2a study of BMS-986231](https://i1.rgstatic.net/publication/318232365_A_Phase_2a_dose-escalation_study_of_the_safety_tolerability_pharmacokinetics_and_haemodynamic_effects_of_BMS-986231_in_hospitalized_patients_with_heart_failure_with_reduced_ejection_fraction_A_Phase_2/links/5972691eaca2728d02481cc5/largepreview.png)
PDF) A Phase 2a dose-escalation study of the safety, tolerability, pharmacokinetics and haemodynamic effects of BMS-986231 in hospitalized patients with heart failure with reduced ejection fraction: A Phase 2a study of BMS-986231
![Perspectives in allergen immunotherapy: 2017 and beyond - Pfaar - 2018 - Allergy - Wiley Online Library Perspectives in allergen immunotherapy: 2017 and beyond - Pfaar - 2018 - Allergy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b1e7198d-c421-406c-b11d-55632cd2ee05/all.2018.73.issue-s104.cover.jpg?trick=1658753041350)